[PubMed] [Google Scholar] 18

[PubMed] [Google Scholar] 18. Our results provide a promising principle for the use of endothelial markers for intratumoral drug delivery. Tumor endotheliumCbased access might offer new opportunities for the imaging and therapy of hepatocellular carcinoma and other liver malignancies. (Fig. ?(Fig.2B).2B). The epitope for ME-9F1 mAb was thus accesible on the intraluminal surface of endothelium. Open in a separate window Figure 2 Immediate binding of ME-9F1 mAb to endothelial cells(A) Image-based immunofluorescence analysis of mAb binding to histological slides after 5 s incubation. ME-9F1 showed immediate concentration-dependent binding to tumor endothelial cells, which was significantly higher than binding to hepatic endothelial cells (and expressed in normal tissues em in vivo /em . J Biol Chem. 2001;276:38795C807. [PubMed] [Google Scholar] 13. Pond SM, Tozer TN, First-pass elimination. Basic concepts and clinical consequences. Clin Pharmacokinet. 1984;9:1C25. [PubMed] [Google Scholar] 14. Flanagan K, Fitzgerald K, Baker J, Regnstrom K, Gardai S, Bard F, Mocci S, Seto P, You M, Larochelle C, Prat A, Chow S, Li L, Vandevert C, Zago W, Lorenzana C, Nishioka C, Hoffman J, Botelho R, Willits C, Tanaka K, Johnston J, Yednock T. Laminin-411 Is a Vascular Ligand for MCAM and Facilitates KX2-391 TH17 Cell Entry into the CNS. PLoS ONE. 2012;7:e40443. [PMC free article] [PubMed] [Google Scholar] 15. Jiang T, Zhuang J, Duan H, Luo Y, Zeng Q, Fan K, Yan H, Lu D, Ye Z, Hao J, Feng J, Yang D, KX2-391 Yan X. CD146 is a coreceptor for VEGFR-2 in tumor angiogenesis. Blood. 2012;120:2330C9. [PubMed] [Google Scholar] 16. Breedis C, Young G. The blood supply of neoplasms in the liver. Am J Pathol. 1954;30:969C77. [PMC free article] [PubMed] [Google Scholar] 17. Martin R, Geller D, Espat J, Kooby D, Sellars M, Goldstein R, Imagawa D, Scoggins C. Safety and efficacy of trans arterial chemoembolization with drug-eluting beads in hepatocellular cancer: a systematic review. Hepatogastroenterology. 2012;59:255C60. [PubMed] [Google Scholar] 18. Giammarile F, Bodei L, Chiesa C, Flux KX2-391 G, Forrer F, Kraeber-Bodere F, Brans B, Lambert B, Konijnenberg M, Borson-Chazot F, Tennvall J, Luster M. EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds. Eur J Nucl Med Mol Imaging. 2011;38:1393C406. [PubMed] [Google Scholar] 19. Kemeny NE, Schwartz L, Gonen M, Yopp A, Gultekin D, D’Angelica MI, Fong Y, Haviland D, Gewirtz AN, Allen P, Jarnagin WR. Treating primary liver cancer with hepatic arterial infusion of floxuridine and dexamethasone: does the addition of systemic bevacizumab improve results? Oncology. 2011;80:153C9. [PMC free article] [PubMed] [Google Scholar] 20. Rahbari NN, Wente MN, Schemmer P, Diener MK, Hoffmann K, Motschall E, Schmidt J, Weitz J, Buchler MW. Systematic review and meta-analysis of the effect of portal triad clamping on outcome after hepatic resection. Br J Surg. 2008;95:424C32. [PubMed] [Google Scholar] 21. Zhao M, Pan X, Layman R, Lustberg MB, Mrozek E, Macrae ER, Wesolowski R, Carothers S, Puhalla S, Shapiro CL, Ramaswamy B. A Rabbit polyclonal to PHYH Phase II study of bevacizumab in combination with trastuzumab and docetaxel in HER2 positive metastatic breast cancer. Invest New Drugs. 2014 [PMC free article] [PubMed] [Google Scholar] 22. Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, Heim W, Berlin J, Baron A, Griffing S, Holmgren E, Ferrara N, Fyfe G, Rogers B, Ross R, Kabbinavar F. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med. 2004;350:2335C42. [PubMed] [Google Scholar] 23. Ott PA, Hodi FS, Robert C. CTLA-4 and PD-1/PD-L1 blockade: new immunotherapeutic modalities with durable clinical benefit in melanoma patients. Clin Cancer Res. 2013;19:5300C9. [PubMed] [Google Scholar] 24. Zhang J, Lai EC, Zhou WP, Fu S, Pan Z, Yang Y, Lau WY, Wu MC. Selective KX2-391 hepatic vascular exclusion versus Pringle manoeuvre in liver resection for tumours encroaching on major hepatic veins. Br J Surg. 2012;99:973C7. [PubMed] [Google Scholar] 25. Forster MR, Rashid OM, Perez MC, Choi J, Chaudhry T, Zager JS. Chemosaturation with percutaneous hepatic perfusion for unresectable metastatic melanoma or sarcoma to the liver: A single institution experience. J Surg Oncol. 2013;109:434C9. [PMC free article] [PubMed] [Google Scholar] 26. Ryschich E, Lizdenis P, Ittrich C, Benner A, Stahl S,.